Emyria encouraged by US FDA”s position on real-world data on CBD regulation – Proactive Investors Australia
CONTEXT: A story of being in the right place at the right time for a SaaS provider| FDA’s increasing interest and support for high-quality RWE in the field of cannabinoid Continue Reading